A PHASE-I STUDY OF RDNA ALPHA-2B INTERFERON AS A 6-WEEK CONTINUOUS INTRAVENOUS-INFUSION

被引:0
作者
SMITH, D
WAGSTAFF, J
THATCHER, N
SCARFFE, H
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:327 / 331
页数:5
相关论文
共 20 条
  • [1] NEUROPSYCHIATRIC MANIFESTATIONS OF HUMAN-LEUKOCYTE INTERFERON THERAPY IN PATIENTS WITH CANCER
    ADAMS, F
    QUESADA, JR
    GUTTERMAN, JU
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (07): : 938 - 941
  • [2] INTRAVENOUS AND INTRAMUSCULAR PHARMACOKINETICS OF RECOMBINANT LEUKOCYTE-A INTERFERON
    BORNEMANN, LD
    SPIEGEL, HE
    DZIEWANOWSKA, ZE
    KROWN, SE
    COLBURN, WA
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (04) : 469 - 471
  • [3] COOPER MR, 1986, CANCER TREAT REP, V70, P473
  • [4] A PHASE-I CLINICAL TOLERANCE STUDY OF RDNA ALPHA2 HUMAN INTERFERON IN PATIENTS WITH NON-RETICULOENDOTHELIAL SYSTEM MALIGNANCIES
    EDELSTEIN, MB
    SCHELLEKENS, H
    LAURENT, T
    GAUCI, L
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (07): : 891 - 894
  • [5] GHEZZI P, 1985, CANCER RES, V45, P3444
  • [6] GRESSER I, 1983, INTERFERON CANCER, P65
  • [7] MATTSON K, 1984, LANCET, V1, P275
  • [8] NETHERSELL A, 1985, INTERFERONS THEIR IM, P133
  • [9] PLASSE T, 1982, CANCER, V50, P27, DOI 10.1002/1097-0142(19820701)50:1<27::AID-CNCR2820500107>3.0.CO
  • [10] 2-F